Erica S Tsang - JoVE Visualize

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Nature Communications|October 8, 2022

Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinomaJames T Topham, Erica S Tsang, Joanna M Karasinska, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2025

PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic CancerJennifer J Knox, Grainne O'Kane, Daniel King, et al.

Nature Communications|July 2, 2025

Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trialJennifer J Knox, Gun Ho Jang, Robert C Grant, et al.

Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Nature Communications|October 8, 2022

Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinomaJames T Topham, Erica S Tsang, Joanna M Karasinska, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2025

PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic CancerJennifer J Knox, Grainne O'Kane, Daniel King, et al.

Nature Communications|July 2, 2025

Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trialJennifer J Knox, Gun Ho Jang, Robert C Grant, et al.

Pageof 4